News | May 06, 2026
Pfizer powers ahead in 2026 with strong Q1 results as pipeline momentum builds
The pharmaceutical giant reported $14.5 billion in revenue, up 5% year-over-year, and reaffirmed its full-year outlook
The pharmaceutical giant reported $14.5 billion in revenue, up 5% year-over-year, and reaffirmed its full-year outlook
Growth was supported by stronger COVID vaccine sales and expanded government supply agreements in international markets
While Drugs for Neglected Diseases initiative (DNDi) drives the R&D for neglected diseases, we collaborate with pharmaceutical companies at multiple stages, including sourcing promising molecules
Reshaped by COVID-19, rising test demand, and a shift toward decentralized diagnostics, qPCR has evolved from niche academic use to a core clinical engine
India leads the shift as wellness tourism integrates healthcare, hospitality, and lifestyle
C. P. Radhakrishnan urged graduates to uphold ethical standards and maintain a commitment to patient care
The start of our Phase 3 trial for an H5 influenza vaccine marks a significant milestone
Marking three years of the National Diagnostics Catapult (NDxC), the conclave launched the Impact Report and unveiled environmental surveillance kits
Outlines nine priority health tracks spanning TB research, digital health, early warning systems and regulatory cooperation
The collaboration promises expanded funding for Thai universities, research institutes, companies, and global research partners working in Thailand
Subscribe To Our Newsletter & Stay Updated
